• Dana-Farber/New Hampshire Oncology-Hematology

    Managing and Interpreting Cancer Risk

    Considerations for Genetic Counseling and Testing

    Monday, October 15, 2012
    5:30 – 7:45 pm
    Dana-Farber/New Hampshire Oncology-Hematology

    Please join us for an evening seminar focused on evaluating and managing cancer risk through genetic counseling and testing. This course has been developed for primary care physicians, gynecologists, gastroenterologists, hematologists/oncologists, surgeons, nurse practitioners, and other interested clinicians. Faculty will present updates that will help physicians:

    • Understand and describe the basic components of a genetic counseling consultation and what a patient can expect when referred for genetic counseling
    • Identify potential risks, benefits, and limitations of genetic testing for inherited cancer syndromes
    • Understand and explain the most common hereditary cancer predispositions
    • Learn the features of a patient’s personal or family history that indicate a hereditary cancer syndrome or increased risk
    • Recognize current recommendations for screening and risk reduction for breast, ovarian, and gastrointestinal cancers

    This course is offered by Dana-Farber/New Hampshire Oncology-Hematology and Southern New Hampshire Area Health Education Center.

    Registration

    This course is free for interested providers. Space is limited.

    To register, contact Carla LaPorte by October 10.
    Email: carla_laporte@dfci.harvard.edu
    Phone: 603-552-9125

    Agenda

    5:30 pm

    Dinner and Networking

    6:00 pm

    Welcome
    Frederick M. Briccetti, MD

    6:10 pm

    Introductions
    Judy E. Garber, MD, MPH

    6:20 pm

    Hereditary Gastrointestinal Cancer Syndromes
    Matthew B. Yurgelun, MD

    6:45 pm

    Hereditary Breast and Ovarian Cancer
    Huma Q. Rana, MD

    7:10 pm

    Cancer Genetic Counseling: Indications for Referral and Implications of Testing
    Claire Healy, MS, CGC

    7:35 pm

    Concluding Remarks
    Frederick M. Briccetti MD and Judy E. Garber, MD, MPH

    Faculty

    Frederick M. Briccetti, MD
    Medical Director, Dana-Farber/New Hampshire Oncology-Hematology;
    Instructor in Medicine, Harvard Medical School

    Judy E. Garber, MD, MPH
    Director, Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute;
    Professor of Medicine, Harvard Medical School

    Claire Healy, MS, CGC
    Genetics Counselor, Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute

    Huma Q. Rana, MD
    Medical Geneticist, Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute;
    Instructor in Medicine, Harvard Medical School

    Matthew B. Yurgelun, MD
    Medical Oncologist, Gastrointestinal Oncology Center and Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute;
    Instructor in Medicine, Harvard Medical School

    Accreditation

    The Southern NH Area Health Education Center, accredited by the NH Medical Society, designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The Southern NH Area Health Education Center is approved as a provider of continuing education in nursing by the New Hampshire Nurses’ Association Commission on Continuing Education which is accredited as an approver of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

    This continuing education activity has been approved for 1.25 contact hours. SNHAHEC Activity Number: 1064

    dana-farber-new-hampshire-oncology-hematology-logo.gif
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms